Status:
COMPLETED
Disparity Between Ultrasound- and Clinical Findings in Psoriatic Arthritis in Remission
Lead Sponsor:
University Hospital, Montpellier
Conditions:
PsA Patients Fulfilling CASPAR Criteria in Remission
Eligibility:
All Genders
18+ years
Brief Summary
Comparison of the proportion of Psoriatic arthritis patients in ultrasound remission (i.e. no power Doppler synovitis, tenosynovitis, dactylitis, enthesitis, PD=0) depending on whether patient and phy...
Detailed Description
Current data indicate limited correlations between Ultrasound- and clinical findings of inflammation (synovitis, tenosynovitis, dactylitis, enthesitis) in psoriatic arthritis (PsA). This can could be ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- PsA patients fulfilling CASPAR criteria in remission as determined by physician, with stable treatment
- Exclusion criteria:
- \- patient simultaneously included in another study with blinded treatment; Steinbrocker class IV patients
Exclusion
Key Trial Info
Start Date :
November 2 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 29 2018
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT03396679
Start Date
November 2 2017
End Date
June 29 2018
Last Update
May 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Lapeyronie
Montpellier, France, 34000